Advertisement

Genetic Approaches to Study Pseudomonas Aeruginosa Protein Antigens

  • Thalia I. Nicas
  • Barbara H. Iglewski
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 185)

Abstract

Pseudomonas aeruginosa produces a large number of extracellular products which may play a role in pathogenesis. We have used genetic techniques to elucidate the relative contribution of these proteins to virulence, and as a method of producing safe toxoids. A mutant has been isolated which produces an immunologically reactive nontoxic form of toxin A, the most toxic extracellular protein produced by P. aeruginosa. Although there are difficulties in production of sufficient quantities of this CRM toxoid, these are likely to be solved by further genetic manipulation. Protection studies with toxin A antibody and studies of mutants deficient in toxin A have confirmed that toxin A plays a role in pathogenesis while clearly showing that toxin A alone cannot totally account for the virulence of P. aeruginosa. Studies of mutants specifically altered in three other products, exoenzyme S, and the two major proteases of P. aeruginosa, elastase and alkaline protease, have clarified the contribution of these products to virulence. Demonstration by genetic studies that exoenzyme S was a major factor in the virulence for one P. aeruginosa strain allowed us to correctly predict that antibody to this product would be protective against infection with that strain.

Keywords

Pseudomonas Aeruginosa Parent Strain Genetic Approach Alkaline Protease Passive Immunization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

ADP

adenosine 5′-diphosphate

NAD

nicotinamide adenine dinucleotide

CRM

cross reactive antigen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bjorn, M. J., Iglewski, B. H., Ives, S. K., Sadoff, J. C. and Vasil, M. L., 1978, Effect of iron on yields of exotoxin A in cultures of Pseudomonas aeruginosa PA103, Infect. Immun 19: 785.PubMedGoogle Scholar
  2. Callahan, L. T. III, Martinez, D., Marburg, S., Tolman, R. L. and Galloway, D. R., 1984, Toxoids of Pseudomonas aeruginosa exotoxin A: Photo-affinity inactivation of purified toxin and purified toxin derivatives, Infect. Immun, 43: 1019.PubMedGoogle Scholar
  3. Cryz, S. J., and Iglewski, B. H., 1983, Toxoids of Pseudomonas aeruginosa toxin A: production by chemical and genetic means, Rev. Infect. Dis, 5: S992.PubMedCrossRefGoogle Scholar
  4. Cryz, S. J., Freidman, R. L. and Iglewski, B. H., 1980, Isolation and characterization of a Pseudomonas aeruginosa mutant producing a non-toxic, immunologically crossreactive toxin A protein, Proc. Natl. Acad. Sci. U.S.A, 77: 7199.PubMedCrossRefGoogle Scholar
  5. Cryz, S. J., Freidman, R. L., Pavloskis, O. R. and Iglewski, B. H., 1981, Effect of formalin toxoiding on Pseudomonas aeruginosa toxin A:biological, chemical, and immunochemical studies, Infect. Immun, 32: 759.PubMedGoogle Scholar
  6. Cryz, S. J., Furer, E., and Germanier, R. 1983a, Passive protection against Pseudomonas aeruginosa infection in an experimental leukopenic mouse model, Infect. Immun, 40: 659.PubMedGoogle Scholar
  7. Cryz, S. J., Furer, E., and Germanier, R. 1983b, Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide, Infect. Immun, 39: 1072.PubMedGoogle Scholar
  8. Gray, G. L., Smith, D. H., Baldridge, J. S., Harkins, R. N., Vasil, M. L., Ellson, Y., and Heynecker, H. L., 1984, Cloning, nucleotide sequencing and expression in E. coli of the exotoxin A structural gene of Pseudomonas aeruginosa,Proc. Nat. Acad. Sci., (in press).Google Scholar
  9. Doring, G., Obernesser, H. J. and Bozenhart, K., 1981, Extracellular toxins of P. aeruginosa II. Effect of two proteases on human immunoglobulins IgG, IgM and secretory IgA, Zbl. Bakt. Hyg. Mikrobiol, 249: 89.Google Scholar
  10. Howe, T. R. and Iglewski, B. H., 1984, Isolation and characterization of alkaline protease deficient mutants of Pseudomonas aeruginosa in vitro and in a mouse eye model, Infect. Immun, 43: 1058.Google Scholar
  11. Iglewski, B. H. and Kabat D., 1975, NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa exotoxin A, Proc. Natl. Acad. Sci. U.S.A, 72: 2284.PubMedCrossRefGoogle Scholar
  12. Iglewski, B. H., Sadoff J. C., Bjorn, M. J. and Maxwell, E. S., 1978, Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyl- transferase distinct from toxin A, Proc. Natl. Acad. Sci. U.S.A, 75: 3211.Google Scholar
  13. Liu, P. V., 1974, Extracellular toxins of Pseudomonas aeruginosa, J. Infect. Dis., 130: 594.Google Scholar
  14. Liu, P. V. and Hsieh, H., 1973. Exotoxins of Pseudomonas aeruginosa III: Characteristics of exotoxin A, J. Infect. Dis, 128: 520.PubMedCrossRefGoogle Scholar
  15. Nicas, T. I. and Iglewski, B. H., 1984a, Isolation and characterization of transposon induced mutants of Pseudomonas aeruginosa deficient in exoenzyme S, Infect. Immun. (in press).Google Scholar
  16. Nicas, T. I. and B. H. Iglewski, 1984b, The contribution of exoproducts to virulence of Pseudomonas aeruginosa, Canadian J. Microbiol., (in press).Google Scholar
  17. Ohman, D. E., Burns, R. P. and Iglewski, B. H., 1980a, Corneal infections of mice with toxin A and elastase mutants of Pseudomonas aeruginosa, J. Infect. Dis, 142: 547.PubMedCrossRefGoogle Scholar
  18. Ohman, D. E., Cryz, S. J. and Iglewski, B. H., 1980b, Isolation and characterization of a Pseudomonas aeruginosa PAO mutant that produces altered elastase, J. Bacteriol, 142: 836.PubMedGoogle Scholar
  19. Ohman, D. E., Sadoff, J. C. and Iglewski, B. H., 1980c, Toxin A deficient mutants of Pseudomonas aeruginosa PA103: Isolation and characterization, Infect. Immun, 28: 899.PubMedGoogle Scholar
  20. Pavlovskis, O. R., Pollack, M., Callahan, L. T. III and Iglewski, B. H., 1977, Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections, Infect. Immun 18: 596.PubMedGoogle Scholar
  21. Pavlovskis, O. R., Edman, D. C., Leppla, S. H., Wretlind, B., Lewis, L. and Martin, K. E., 1981, Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with toxin A, Infect. Immun 24: 181.Google Scholar
  22. Pollack, M. and Prescott, R. K., 1982, Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization, J. Infect. Dis, 145: 688.PubMedCrossRefGoogle Scholar
  23. Snell, K., Holder, I. A., Leppla, S. H. and Saelinger, C. B., 1978, Role of exotoxin A and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa, Infect. Immun, 19: 839.Google Scholar
  24. Sokol, P. A., Iglewski, B. H., Hager, T. A., Sadoff, J. C., Cross, A. S., McManus, A., Farber, B. F., and Iglewski, W. F., 1981, Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosa, Infect. Immun, 34: 147.Google Scholar
  25. Sokol, P. A., Cox, C. D., and Iglewski, B. H., 1982, Pseudomonas aeruginosa mutants altered in their sensitivity to the effect of iron on toxin A or elastase yields. J. Bacteriol 151: 783.PubMedGoogle Scholar
  26. Vasil, D. E., Kabat, D. and Iglewski, B. H., 1977, Structure activity relationships of an exotoxin of Pseudomonas aeruginosa, Infect. Immun, 16: 353.PubMedGoogle Scholar
  27. Walker, H. C., McCleod, G. C., Leppla, S. H., Wretlind, B. and Mason, A. D., 1979, Evaluation of Pseudomonas aeruginosa toxin A in experimental rat burn wound specis, Infect. Immun, 25: 828.PubMedGoogle Scholar
  28. Woods, D. E., and Iglewski, B. H., 1983, Toxins of Pseudomonas aeruginosa: new perspectives, Rev. Infect. Dis, 5: S715.PubMedCrossRefGoogle Scholar
  29. Wretlind, B. and Pavlovskis, O. R., 1983, Pseudomonas aeruginosa proteases and their role in Pseudomonas infections, Rev. Infect. Dis. 5: S998.Google Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Thalia I. Nicas
    • 1
  • Barbara H. Iglewski
    • 1
  1. 1.Department of Microbiology and ImmunologyOregon Health Sciences UniversityPortlandUSA

Personalised recommendations